TRIFLUOPERAZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trifluoperazine Hydrochloride, and what generic alternatives are available?
Trifluoperazine Hydrochloride is a drug marketed by Chartwell Rx, Wockhardt, Athem, Duramed Pharms Barr, Ivax Pharms, Mylan, Sandoz, and Watson Labs. and is included in twenty NDAs.
The generic ingredient in TRIFLUOPERAZINE HYDROCHLORIDE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trifluoperazine Hydrochloride
A generic version of TRIFLUOPERAZINE HYDROCHLORIDE was approved as trifluoperazine hydrochloride by SANDOZ on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIFLUOPERAZINE HYDROCHLORIDE?
- What are the global sales for TRIFLUOPERAZINE HYDROCHLORIDE?
- What is Average Wholesale Price for TRIFLUOPERAZINE HYDROCHLORIDE?
Summary for TRIFLUOPERAZINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 20 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 151 |
Clinical Trials: | 7 |
Patent Applications: | 172 |
DailyMed Link: | TRIFLUOPERAZINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for TRIFLUOPERAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Adrianna Vlachos | Phase 1/Phase 2 |
Lindner Center of HOPE | Phase 2 |
Alphacait, LLC | Phase 2 |
Pharmacology for TRIFLUOPERAZINE HYDROCHLORIDE
Drug Class | Phenothiazine |